Terms: = Breast cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Treatment
342 results:
1. Is the QCI framework suited for monitoring outcomes and costs in a teaching hospital using value-based healthcare principles? A retrospective cohort study.
van Veghel W; van Dijk SC; Klem TM; Weel AE; Bügel JB; Birnie E
BMJ Open; 2024 May; 14(5):e080257. PubMed ID: 38692726
[TBL] [Abstract] [Full Text] [Related]
2. Clinical assessment of momelotinib drug-drug interactions via CYP3A metabolism and transporters.
Ho YL; Gorycki P; Ferron-Brady G; Martin P; Vlasakakis G
Clin Transl Sci; 2024 Apr; 17(4):e13799. PubMed ID: 38634429
[TBL] [Abstract] [Full Text] [Related]
3.
Diwanji D; Onishi N; Hathi DK; Lawhn-Heath C; Kornak J; Li W; Guo R; Molina-Vega J; Seo Y; Flavell RR; Heditsian D; Brain S; Esserman LJ; Joe BN; Hylton NM; Jones EF; Ray KM
Radiol Imaging Cancer; 2024 Mar; 6(2):e230082. PubMed ID: 38551406
[TBL] [Abstract] [Full Text] [Related]
4. Detection of HER2 expression using
Zhao L; Xing Y; Liu C; Ma S; Huang W; Cheng Z; Zhao J
Breast Cancer Res; 2024 Mar; 26(1):40. PubMed ID: 38459598
[TBL] [Abstract] [Full Text] [Related]
5. Promising Candidate Prognostic Biomarkers in [
Hovhannisyan-Baghdasarian N; Luporsi M; Captier N; Nioche C; Cuplov V; Woff E; Hegarat N; Livartowski A; Girard N; Buvat I; Orlhac F
J Nucl Med; 2024 Apr; 65(4):635-642. PubMed ID: 38453361
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration.
Piscitelli J; Reddy MB; Wollenberg L; Del Frari L; Gong J; Wood L; Zhang Y; Matschke K; Williams JH
Clin Pharmacokinet; 2024 Apr; 63(4):483-496. PubMed ID: 38424308
[TBL] [Abstract] [Full Text] [Related]
7. [Fluorescence lymphography for sentinal lymph node biopsy in breast cancer].
Bozhok AA; Kashchenko VA; Ratnikov VA; Gornov SV; Suvorova YV; Manelov AE
Khirurgiia (Mosk); 2024; (2. Vyp. 2):48-54. PubMed ID: 38380464
[TBL] [Abstract] [Full Text] [Related]
8. Protective effects of exercise on cardiotoxicity induced by breast cancer treatments: A systematic review and meta-analysis.
Fernández-Casas A; Leirós-Rodríguez R; Hernandez-Lucas P; González-Represas A
Maturitas; 2024 May; 183():107932. PubMed ID: 38325133
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of Individualized Silicone Rubber Bolus Using Fan Beam Computed Tomography in Postmastectomy Radiotherapy: A Dosimetric Evaluation and Skin Acute Radiation Dermatitis Survey.
Chen XM; Xu CD; Zeng LP; Huang XT; Chen AQ; Liu L; Lin LW; Jia LC; Li H; Jiang XB
Technol Cancer Res Treat; 2024; 23():15330338241229367. PubMed ID: 38297814
[No Abstract] [Full Text] [Related]
10. Comparative pharmacokinetics of tyrosine kinase inhibitor, lapatinib, in dogs and cats following single oral administration.
Yu TW; Yamamoto H; Morita S; Fukushima R; Elbadawy M; Usui T; Sasaki K
J Vet Med Sci; 2024 Mar; 86(3):317-321. PubMed ID: 38281758
[TBL] [Abstract] [Full Text] [Related]
11. Mechanisms Behind the Pharmacological Application of Biochanin-A: A review.
Anuranjana PV; Beegum F; K P D; George KT; Viswanatha GL; Nayak PG; Kanwal A; Kishore A; Shenoy RR; Nandakumar K
F1000Res; 2023; 12():107. PubMed ID: 38106650
[TBL] [Abstract] [Full Text] [Related]
12. In vivo dose measurements for tangential field-in-field ultra-hypofractionated breast radiotherapy.
Abdelmajeed M; Attalla EM; Elshemey WM; Elfiky AA; Awadly ME; Eldesoky AR
J Med Imaging Radiat Sci; 2024 Mar; 55(1):37-44. PubMed ID: 38042641
[TBL] [Abstract] [Full Text] [Related]
13. The Effect of BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open-Label, Non-randomized, 2-Period Fixed-Sequence Trial in Healthy Subjects.
Choi H; Huang F; Flack M
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):197-207. PubMed ID: 37960990
[TBL] [Abstract] [Full Text] [Related]
14. Quality by design approach-based fabrication and evaluation of self-nanoemulsifying drug delivery system for improved delivery of venetoclax.
Rajana N; Chary PS; Pooja YS; Bhavana V; Singh H; Guru SK; Singh SB; Mehra NK
Drug Deliv Transl Res; 2024 May; 14(5):1277-1300. PubMed ID: 37953430
[TBL] [Abstract] [Full Text] [Related]
15. Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma.
Drouyer A; Beaussire L; Jorda P; Leheurteur M; Guillemet C; Berghian A; Georgescu D; Di Fiore F; Perdrix A; Clatot F
BMC Cancer; 2023 Nov; 23(1):1061. PubMed ID: 37924026
[TBL] [Abstract] [Full Text] [Related]
16. Verteporfin Suppresses YAP-Induced Glycolysis in breast cancer Cells.
Chen H; Zhang LF; Miao Y; Xi Y; Li X; Liu MF; Zhang M; Li B
J Invest Surg; 2023 Dec; 36(1):2266732. PubMed ID: 37828756
[TBL] [Abstract] [Full Text] [Related]
17. Assessment of the PARP inhibitor talazoparib photosafety profile.
Mateos-Pujante A; Jiménez MC; Andreu I
Biomed Pharmacother; 2023 Nov; 167():115593. PubMed ID: 37793275
[TBL] [Abstract] [Full Text] [Related]
18. Novel Cytochrome P450-3A4 Enzymatic Nanobiosensor for Lapatinib (a breast cancer Drug) Developed on a Poly(anilino-co-4-aminobenzoic Acid-Green-Synthesised Indium Nanoparticle) Platform.
January JL; Tshobeni ZZ; Ngema NPP; Jijana AN; Iwuoha EI; Mulaudzi T; Douman SF; Ajayi RF
Biosensors (Basel); 2023 Sep; 13(9):. PubMed ID: 37754131
[TBL] [Abstract] [Full Text] [Related]
19. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
20. TGMIL: A hybrid multi-instance learning model based on the Transformer and the Graph Attention Network for whole-slide images classification of renal cell carcinoma.
Sun X; Li W; Fu B; Peng Y; He J; Wang L; Yang T; Meng X; Li J; Wang J; Huang P; Wang R
Comput Methods Programs Biomed; 2023 Dec; 242():107789. PubMed ID: 37722310
[TBL] [Abstract] [Full Text] [Related]
[Next]
